539997 Stock Overview
Together with its subsidiary, manufactures, buys, sells, and deals finished pharmaceutical formulations in India and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 539997 from our risk checks.
My Notes
Capture your thoughts, links and company narrative
Kwality Pharmaceuticals Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹866.80 |
| 52 Week High | ₹961.15 |
| 52 Week Low | ₹385.00 |
| Beta | 0.13 |
| 1 Month Change | -3.68% |
| 3 Month Change | 9.13% |
| 1 Year Change | 117.43% |
| 3 Year Change | -4.96% |
| 5 Year Change | 3,292.56% |
| Change since IPO | 3,795.73% |
Recent News & Updates
Recent updates
Shareholder Returns
| 539997 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -3.3% | 2.0% | -0.3% |
| 1Y | 117.4% | 39.5% | 16.3% |
Return vs Industry: 539997 exceeded the Indian Pharmaceuticals industry which returned 39.5% over the past year.
Return vs Market: 539997 exceeded the Indian Market which returned 16.3% over the past year.
Price Volatility
| 539997 volatility | |
|---|---|
| 539997 Average Weekly Movement | 6.9% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.1% |
Stable Share Price: 539997 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 539997's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1983 | 806 | Ramesh Arora | www.kwalitypharma.com |
Kwality Pharmaceuticals Limited, together with its subsidiary, manufactures, buys, sells, and deals finished pharmaceutical formulations in India and internationally. It offers its products in various dosage forms, including liquid orals, powder for oral suspension, tablets, capsules, sterile powder for injections, small volume injectables, ointments/cream, external preparations, ORS, eye/ear drops, sanitizers, suppositories, injectable vials and ampoules, lyophilized and covid products, syrups, daunorubicin, and other various categories, such as Beta Lactam, non-Beta Lactam, hormones, cytotoxic (oncology), and effervescent. The company also provides intermediates, chemicals, extracts, alkaloids, toilet requisites, beverages, and other medical preparations.
Kwality Pharmaceuticals Limited Fundamentals Summary
| 539997 fundamental statistics | |
|---|---|
| Market cap | ₹9.03b |
| Earnings (TTM) | ₹289.64m |
| Revenue (TTM) | ₹3.40b |
31.1x
P/E Ratio2.6x
P/S RatioIs 539997 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 539997 income statement (TTM) | |
|---|---|
| Revenue | ₹3.40b |
| Cost of Revenue | ₹1.74b |
| Gross Profit | ₹1.66b |
| Other Expenses | ₹1.37b |
| Earnings | ₹289.64m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 14, 2025
| Earnings per share (EPS) | 27.91 |
| Gross Margin | 48.92% |
| Net Profit Margin | 8.51% |
| Debt/Equity Ratio | 42.8% |
How did 539997 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/31 11:46 |
| End of Day Share Price | 2024/12/31 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Kwality Pharmaceuticals Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|